nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R3—cardiovascular system—atherosclerosis	0.00902	0.116	CbGeAlD
Isoprenaline—PIK3R3—adipose tissue—atherosclerosis	0.00796	0.102	CbGeAlD
Isoprenaline—PIK3R1—adipose tissue—atherosclerosis	0.0068	0.0874	CbGeAlD
Isoprenaline—ADRB3—connective tissue—atherosclerosis	0.00627	0.0806	CbGeAlD
Isoprenaline—MAPK1—connective tissue—atherosclerosis	0.00604	0.0777	CbGeAlD
Isoprenaline—ADRBK1—cardiovascular system—atherosclerosis	0.00533	0.0686	CbGeAlD
Isoprenaline—MAPK1—cardiovascular system—atherosclerosis	0.00526	0.0676	CbGeAlD
Isoprenaline—ADRB3—adipose tissue—atherosclerosis	0.00481	0.0619	CbGeAlD
Isoprenaline—PIK3R1—liver—atherosclerosis	0.00477	0.0613	CbGeAlD
Isoprenaline—ADRBK1—adipose tissue—atherosclerosis	0.0047	0.0605	CbGeAlD
Isoprenaline—MAPK1—adipose tissue—atherosclerosis	0.00463	0.0596	CbGeAlD
Isoprenaline—Masoprocol—ALOX5—atherosclerosis	0.00394	0.824	CrCbGaD
Isoprenaline—MAPK1—liver—atherosclerosis	0.00325	0.0418	CbGeAlD
Isoprenaline—Arrhythmia—Rosuvastatin—atherosclerosis	0.00301	0.0243	CcSEcCtD
Isoprenaline—Angina pectoris—Niacin—atherosclerosis	0.00299	0.0241	CcSEcCtD
Isoprenaline—Angina pectoris—Pravastatin—atherosclerosis	0.00294	0.0237	CcSEcCtD
Isoprenaline—Flushing—Lovastatin—atherosclerosis	0.00265	0.0214	CcSEcCtD
Isoprenaline—Sweating—Niacin—atherosclerosis	0.00262	0.0212	CcSEcCtD
Isoprenaline—Flushing—Ezetimibe—atherosclerosis	0.0026	0.021	CcSEcCtD
Isoprenaline—ADRB1—connective tissue—atherosclerosis	0.00256	0.033	CbGeAlD
Isoprenaline—Flushing—Simvastatin—atherosclerosis	0.00248	0.02	CcSEcCtD
Isoprenaline—Vision blurred—Lovastatin—atherosclerosis	0.00235	0.0189	CcSEcCtD
Isoprenaline—Tremor—Lovastatin—atherosclerosis	0.00233	0.0188	CcSEcCtD
Isoprenaline—Flushing—Niacin—atherosclerosis	0.00228	0.0184	CcSEcCtD
Isoprenaline—Flushing—Pravastatin—atherosclerosis	0.00224	0.0181	CcSEcCtD
Isoprenaline—Vertigo—Lovastatin—atherosclerosis	0.00224	0.018	CcSEcCtD
Isoprenaline—ADRB1—cardiovascular system—atherosclerosis	0.00223	0.0287	CbGeAlD
Isoprenaline—Vision blurred—Simvastatin—atherosclerosis	0.00219	0.0177	CcSEcCtD
Isoprenaline—Arrhythmia—Niacin—atherosclerosis	0.00219	0.0177	CcSEcCtD
Isoprenaline—Tremor—Simvastatin—atherosclerosis	0.00218	0.0176	CcSEcCtD
Isoprenaline—Insomnia—Rosuvastatin—atherosclerosis	0.00217	0.0175	CcSEcCtD
Isoprenaline—Arrhythmia—Pravastatin—atherosclerosis	0.00216	0.0174	CcSEcCtD
Isoprenaline—Palpitations—Ezetimibe—atherosclerosis	0.00216	0.0174	CcSEcCtD
Isoprenaline—Hypertension—Ezetimibe—atherosclerosis	0.00211	0.017	CcSEcCtD
Isoprenaline—Tension—Niacin—atherosclerosis	0.0021	0.0169	CcSEcCtD
Isoprenaline—Vertigo—Simvastatin—atherosclerosis	0.00209	0.0169	CcSEcCtD
Isoprenaline—Nervousness—Niacin—atherosclerosis	0.00208	0.0168	CcSEcCtD
Isoprenaline—Tension—Pravastatin—atherosclerosis	0.00207	0.0167	CcSEcCtD
Isoprenaline—Nervousness—Pravastatin—atherosclerosis	0.00204	0.0165	CcSEcCtD
Isoprenaline—Vision blurred—Niacin—atherosclerosis	0.00201	0.0163	CcSEcCtD
Isoprenaline—Vision blurred—Pravastatin—atherosclerosis	0.00198	0.016	CcSEcCtD
Isoprenaline—Tremor—Pravastatin—atherosclerosis	0.00197	0.0159	CcSEcCtD
Isoprenaline—ADRB1—adipose tissue—atherosclerosis	0.00197	0.0253	CbGeAlD
Isoprenaline—Vertigo—Niacin—atherosclerosis	0.00192	0.0155	CcSEcCtD
Isoprenaline—Vertigo—Pravastatin—atherosclerosis	0.00189	0.0153	CcSEcCtD
Isoprenaline—Palpitations—Niacin—atherosclerosis	0.00189	0.0152	CcSEcCtD
Isoprenaline—Insomnia—Lovastatin—atherosclerosis	0.00184	0.0148	CcSEcCtD
Isoprenaline—Hypertension—Pravastatin—atherosclerosis	0.00182	0.0147	CcSEcCtD
Isoprenaline—Dyspnoea—Lovastatin—atherosclerosis	0.00181	0.0146	CcSEcCtD
Isoprenaline—Insomnia—Ezetimibe—atherosclerosis	0.0018	0.0145	CcSEcCtD
Isoprenaline—Dyspnoea—Ezetimibe—atherosclerosis	0.00178	0.0143	CcSEcCtD
Isoprenaline—Asthenia—Rosuvastatin—atherosclerosis	0.00172	0.0139	CcSEcCtD
Isoprenaline—Insomnia—Simvastatin—atherosclerosis	0.00172	0.0139	CcSEcCtD
Isoprenaline—Tachycardia—Niacin—atherosclerosis	0.0017	0.0137	CcSEcCtD
Isoprenaline—Dyspnoea—Simvastatin—atherosclerosis	0.00169	0.0137	CcSEcCtD
Isoprenaline—Hyperhidrosis—Niacin—atherosclerosis	0.00169	0.0136	CcSEcCtD
Isoprenaline—Hyperhidrosis—Pravastatin—atherosclerosis	0.00166	0.0134	CcSEcCtD
Isoprenaline—Hypotension—Niacin—atherosclerosis	0.00163	0.0132	CcSEcCtD
Isoprenaline—Dizziness—Rosuvastatin—atherosclerosis	0.00159	0.0128	CcSEcCtD
Isoprenaline—Insomnia—Niacin—atherosclerosis	0.00158	0.0127	CcSEcCtD
Isoprenaline—Dyspnoea—Niacin—atherosclerosis	0.00156	0.0126	CcSEcCtD
Isoprenaline—Insomnia—Pravastatin—atherosclerosis	0.00155	0.0125	CcSEcCtD
Isoprenaline—Dyspnoea—Pravastatin—atherosclerosis	0.00153	0.0124	CcSEcCtD
Isoprenaline—Headache—Rosuvastatin—atherosclerosis	0.0015	0.0121	CcSEcCtD
Isoprenaline—Asthenia—Lovastatin—atherosclerosis	0.00146	0.0118	CcSEcCtD
Isoprenaline—Asthenia—Ezetimibe—atherosclerosis	0.00143	0.0115	CcSEcCtD
Isoprenaline—Nausea—Rosuvastatin—atherosclerosis	0.00142	0.0115	CcSEcCtD
Isoprenaline—Asthenia—Simvastatin—atherosclerosis	0.00136	0.011	CcSEcCtD
Isoprenaline—Dizziness—Lovastatin—atherosclerosis	0.00134	0.0108	CcSEcCtD
Isoprenaline—Dizziness—Ezetimibe—atherosclerosis	0.00132	0.0106	CcSEcCtD
Isoprenaline—Headache—Lovastatin—atherosclerosis	0.00127	0.0103	CcSEcCtD
Isoprenaline—CYP1A1—adipose tissue—atherosclerosis	0.00127	0.0163	CbGeAlD
Isoprenaline—Dizziness—Simvastatin—atherosclerosis	0.00126	0.0101	CcSEcCtD
Isoprenaline—Asthenia—Niacin—atherosclerosis	0.00125	0.0101	CcSEcCtD
Isoprenaline—Headache—Ezetimibe—atherosclerosis	0.00125	0.0101	CcSEcCtD
Isoprenaline—Asthenia—Pravastatin—atherosclerosis	0.00123	0.00995	CcSEcCtD
Isoprenaline—Nausea—Lovastatin—atherosclerosis	0.00121	0.00974	CcSEcCtD
Isoprenaline—Headache—Simvastatin—atherosclerosis	0.00119	0.0096	CcSEcCtD
Isoprenaline—Nausea—Ezetimibe—atherosclerosis	0.00118	0.00955	CcSEcCtD
Isoprenaline—Dizziness—Niacin—atherosclerosis	0.00115	0.00931	CcSEcCtD
Isoprenaline—Dizziness—Pravastatin—atherosclerosis	0.00114	0.00917	CcSEcCtD
Isoprenaline—Nausea—Simvastatin—atherosclerosis	0.00113	0.00911	CcSEcCtD
Isoprenaline—Headache—Niacin—atherosclerosis	0.00109	0.00882	CcSEcCtD
Isoprenaline—Headache—Pravastatin—atherosclerosis	0.00108	0.00868	CcSEcCtD
Isoprenaline—Nausea—Niacin—atherosclerosis	0.00104	0.00836	CcSEcCtD
Isoprenaline—Nausea—Pravastatin—atherosclerosis	0.00102	0.00823	CcSEcCtD
Isoprenaline—CYP1A1—liver—atherosclerosis	0.00089	0.0114	CbGeAlD
Isoprenaline—Epinephrine—TNF—atherosclerosis	0.000842	0.176	CrCbGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL5—atherosclerosis	2.06e-05	2.6e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—INS—atherosclerosis	2.06e-05	2.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—STAT3—atherosclerosis	2.06e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KNG1—atherosclerosis	2.06e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—STAT3—atherosclerosis	2.06e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IGF1—atherosclerosis	2.06e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—atherosclerosis	2.05e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—AKT1—atherosclerosis	2.05e-05	2.58e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	2.05e-05	2.58e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	2.04e-05	2.58e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL2—atherosclerosis	2.04e-05	2.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCL8—atherosclerosis	2.04e-05	2.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—atherosclerosis	2.04e-05	2.57e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PLG—atherosclerosis	2.04e-05	2.57e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SCARB1—atherosclerosis	2.03e-05	2.55e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LPL—atherosclerosis	2.02e-05	2.54e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCL8—atherosclerosis	2.01e-05	2.53e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IGF1—atherosclerosis	2.01e-05	2.53e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	2.01e-05	2.53e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PLG—atherosclerosis	1.99e-05	2.51e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.97e-05	2.49e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—AKT1—atherosclerosis	1.97e-05	2.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MAPK3—atherosclerosis	1.97e-05	2.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—MAPK3—atherosclerosis	1.96e-05	2.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PRKCG—atherosclerosis	1.96e-05	2.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SERPINE1—atherosclerosis	1.95e-05	2.46e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—AKT1—atherosclerosis	1.94e-05	2.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—atherosclerosis	1.94e-05	2.44e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	1.93e-05	2.43e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMGCR—atherosclerosis	1.91e-05	2.41e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—atherosclerosis	1.91e-05	2.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SPP1—atherosclerosis	1.91e-05	2.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFB1—atherosclerosis	1.91e-05	2.4e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SERPINE1—atherosclerosis	1.9e-05	2.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCL8—atherosclerosis	1.9e-05	2.4e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—STAT3—atherosclerosis	1.9e-05	2.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—atherosclerosis	1.9e-05	2.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SERPINE1—atherosclerosis	1.89e-05	2.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—AKT1—atherosclerosis	1.89e-05	2.39e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	1.89e-05	2.38e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IFNG—atherosclerosis	1.87e-05	2.35e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOS3—atherosclerosis	1.86e-05	2.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP3—atherosclerosis	1.86e-05	2.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF2—atherosclerosis	1.85e-05	2.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—atherosclerosis	1.84e-05	2.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NFKB1—atherosclerosis	1.83e-05	2.3e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP3—atherosclerosis	1.82e-05	2.3e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOS3—atherosclerosis	1.82e-05	2.29e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—atherosclerosis	1.82e-05	2.29e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF2—atherosclerosis	1.81e-05	2.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MAPK3—atherosclerosis	1.81e-05	2.29e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS3—atherosclerosis	1.81e-05	2.28e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.8e-05	2.27e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NFKB1—atherosclerosis	1.8e-05	2.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MAPK8—atherosclerosis	1.79e-05	2.26e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—AKT1—atherosclerosis	1.79e-05	2.26e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.78e-05	2.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—atherosclerosis	1.77e-05	2.23e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.77e-05	2.23e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAPK8—atherosclerosis	1.77e-05	2.23e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PDGFB—atherosclerosis	1.77e-05	2.23e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—atherosclerosis	1.76e-05	2.22e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.76e-05	2.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—atherosclerosis	1.76e-05	2.22e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.76e-05	2.22e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—atherosclerosis	1.75e-05	2.21e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.75e-05	2.2e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—atherosclerosis	1.75e-05	2.2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.73e-05	2.18e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.73e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AGT—atherosclerosis	1.73e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.72e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.72e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—atherosclerosis	1.72e-05	2.16e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCA1—atherosclerosis	1.7e-05	2.15e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—atherosclerosis	1.69e-05	2.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LEP—atherosclerosis	1.69e-05	2.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.68e-05	2.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—atherosclerosis	1.68e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CAV1—atherosclerosis	1.67e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.67e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOA1—atherosclerosis	1.67e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—atherosclerosis	1.67e-05	2.1e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—atherosclerosis	1.66e-05	2.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—atherosclerosis	1.65e-05	2.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL8—atherosclerosis	1.65e-05	2.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—STAT3—atherosclerosis	1.64e-05	2.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—atherosclerosis	1.64e-05	2.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—atherosclerosis	1.63e-05	2.06e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.63e-05	2.06e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—atherosclerosis	1.63e-05	2.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.63e-05	2.05e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.62e-05	2.04e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—STAT3—atherosclerosis	1.62e-05	2.04e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ESR1—atherosclerosis	1.61e-05	2.03e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL8—atherosclerosis	1.61e-05	2.03e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—atherosclerosis	1.61e-05	2.03e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—atherosclerosis	1.61e-05	2.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—atherosclerosis	1.6e-05	2.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—F2—atherosclerosis	1.59e-05	2.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.59e-05	2.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—atherosclerosis	1.59e-05	2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.59e-05	2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—atherosclerosis	1.57e-05	1.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MAPK3—atherosclerosis	1.57e-05	1.98e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—atherosclerosis	1.56e-05	1.96e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NFKB1—atherosclerosis	1.55e-05	1.96e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—atherosclerosis	1.55e-05	1.95e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAPK3—atherosclerosis	1.54e-05	1.95e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—atherosclerosis	1.53e-05	1.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MAPK8—atherosclerosis	1.53e-05	1.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CG—atherosclerosis	1.53e-05	1.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—atherosclerosis	1.52e-05	1.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—atherosclerosis	1.51e-05	1.9e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.51e-05	1.9e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—atherosclerosis	1.5e-05	1.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—atherosclerosis	1.49e-05	1.88e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—atherosclerosis	1.49e-05	1.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NFKB1—atherosclerosis	1.48e-05	1.86e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.47e-05	1.86e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.47e-05	1.85e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMOX1—atherosclerosis	1.46e-05	1.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—MAPK3—atherosclerosis	1.46e-05	1.84e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—atherosclerosis	1.46e-05	1.84e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK8—atherosclerosis	1.45e-05	1.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—atherosclerosis	1.45e-05	1.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—INS—atherosclerosis	1.44e-05	1.82e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NFKB1—atherosclerosis	1.44e-05	1.82e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.44e-05	1.82e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.44e-05	1.82e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.44e-05	1.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—atherosclerosis	1.44e-05	1.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—atherosclerosis	1.44e-05	1.81e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.43e-05	1.8e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.42e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—atherosclerosis	1.42e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK8—atherosclerosis	1.42e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—atherosclerosis	1.42e-05	1.78e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.41e-05	1.78e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.41e-05	1.78e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOB—atherosclerosis	1.4e-05	1.77e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—STAT3—atherosclerosis	1.4e-05	1.76e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1—atherosclerosis	1.4e-05	1.76e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.4e-05	1.76e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.39e-05	1.76e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.38e-05	1.73e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTM1—atherosclerosis	1.36e-05	1.72e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—F2—atherosclerosis	1.36e-05	1.71e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.35e-05	1.7e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—atherosclerosis	1.34e-05	1.69e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—LPL—atherosclerosis	1.34e-05	1.69e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MAPK3—atherosclerosis	1.33e-05	1.68e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—F2—atherosclerosis	1.33e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—STAT3—atherosclerosis	1.33e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SERPINE1—atherosclerosis	1.33e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—atherosclerosis	1.33e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—atherosclerosis	1.33e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—atherosclerosis	1.32e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—atherosclerosis	1.31e-05	1.65e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GPX1—atherosclerosis	1.31e-05	1.64e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.3e-05	1.64e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—STAT3—atherosclerosis	1.3e-05	1.63e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—STAT3—atherosclerosis	1.29e-05	1.63e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.27e-05	1.6e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CD36—atherosclerosis	1.27e-05	1.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK3—atherosclerosis	1.27e-05	1.6e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—atherosclerosis	1.27e-05	1.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—atherosclerosis	1.26e-05	1.59e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.25e-05	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK3—atherosclerosis	1.24e-05	1.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MAPK3—atherosclerosis	1.23e-05	1.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—atherosclerosis	1.23e-05	1.55e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—INS—atherosclerosis	1.23e-05	1.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—atherosclerosis	1.22e-05	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.22e-05	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.21e-05	1.53e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—atherosclerosis	1.2e-05	1.52e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—INS—atherosclerosis	1.2e-05	1.52e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—atherosclerosis	1.2e-05	1.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—atherosclerosis	1.2e-05	1.51e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.19e-05	1.5e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.18e-05	1.49e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARA—atherosclerosis	1.18e-05	1.49e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.16e-05	1.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—atherosclerosis	1.15e-05	1.44e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AGT—atherosclerosis	1.14e-05	1.44e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.13e-05	1.42e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—atherosclerosis	1.13e-05	1.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL8—atherosclerosis	1.12e-05	1.42e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—atherosclerosis	1.12e-05	1.41e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAV1—atherosclerosis	1.11e-05	1.4e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOA1—atherosclerosis	1.11e-05	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.11e-05	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.08e-05	1.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—atherosclerosis	1.07e-05	1.35e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—atherosclerosis	1.06e-05	1.33e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.06e-05	1.33e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—atherosclerosis	1.04e-05	1.31e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—atherosclerosis	1.02e-05	1.29e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—atherosclerosis	1.02e-05	1.28e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CG—atherosclerosis	1.01e-05	1.28e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NFKB1—atherosclerosis	1.01e-05	1.27e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK8—atherosclerosis	9.88e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—atherosclerosis	9.86e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARG—atherosclerosis	9.77e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—atherosclerosis	9.76e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—INS—atherosclerosis	9.58e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	9.57e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	9.37e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—atherosclerosis	9.28e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	9.25e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—atherosclerosis	9.12e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—atherosclerosis	9.1e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—atherosclerosis	9.06e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	9.05e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT3—atherosclerosis	9.03e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—atherosclerosis	9.01e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—atherosclerosis	9e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—atherosclerosis	8.91e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—atherosclerosis	8.78e-06	1.11e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—atherosclerosis	8.66e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK3—atherosclerosis	8.63e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	8.57e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—atherosclerosis	8.56e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—atherosclerosis	8.47e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	8.42e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—atherosclerosis	8.4e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	8.4e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	8.38e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—atherosclerosis	8.37e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—atherosclerosis	8.36e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—atherosclerosis	8.31e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	8.24e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	8.22e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	7.78e-06	9.8e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT3—atherosclerosis	7.7e-06	9.7e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—atherosclerosis	7.68e-06	9.68e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	7.61e-06	9.59e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT3—atherosclerosis	7.53e-06	9.49e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	7.36e-06	9.27e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	7.2e-06	9.07e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	7.14e-06	8.99e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	6.98e-06	8.8e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—atherosclerosis	6.31e-06	7.95e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—atherosclerosis	5.82e-06	7.34e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—atherosclerosis	5.38e-06	6.78e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—atherosclerosis	5.26e-06	6.63e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—atherosclerosis	4.96e-06	6.25e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.85e-06	6.12e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—atherosclerosis	3.86e-06	4.87e-06	CbGpPWpGaD
